Cantor Fitzgerald restated their overweight rating on shares of Vincerx Pharma (NASDAQ:VINC – Free Report) in a research report released on Tuesday morning, Benzinga reports. Vincerx Pharma Stock Performance Shares of VINC opened at $0.98 on Tuesday. The stock has a market cap of $20.98 million, a PE ratio of -0.52 and a beta of […]